The nuclear expression or overexpression of TRIM24 is frequently linked to a worse prognosis for patients, e.g., in breast cancer [25], cervical cancer [26], or non-small cell lung cancer (NSCLC) [27]. Here, TRIM24 is linked to breast cancer.